Contacts
Every person and organization shaping the peptide landscape — researchers publishing the science, clinicians applying it, influencers amplifying it, and pharma companies bringing it to market.
Podcasters, biohackers, and content creators shaping the peptide conversation
Scientists and academics publishing the foundational peptide science
Physicians and practitioners working with peptide therapy
Companies developing and manufacturing FDA-approved peptide-based drugs
Featured
Andrew Huberman is an associate professor of neurobiology and ophthalmology at Stanford University, known for his popular science podcast 'Huberman Lab'. He has a background in psychology and neuroscience and explores various topics related to health, learning, and behavior.
Ben Greenfield is a triathlete, personal trainer, and biohacking influencer known for his work in nutrition and health optimization.
Bryan Johnson is an American entrepreneur and venture capitalist, known for founding Kernel and Braintree. He focuses on brain technology and anti-aging initiatives.
Derek MPMD is an influencer in the peptide, longevity, and biohacking sectors, known for discussing various health markers and peptides that can influence bodily functions.
Eli Lilly was an American businessman who founded Eli Lilly and Company, a pharmaceutical company known for developing medications including tirzepatide and dulaglutide.
Novo Nordisk is a Danish pharmaceutical company focused on diabetes and obesity treatments, known for products like semaglutide and liraglutide.
Peter Attia is a Canadian-American author and former researcher known for his work in longevity medicine, particularly through the lens of nutrition, exercise, and biochemistry.
Predrag Sikiric is a researcher focusing on the therapeutic applications of peptides, particularly BPC-157.